|
| Status |
Public on Jul 13, 2017 |
| Title |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
28619718 |
| Submission date |
Oct 14, 2016 |
| Last update date |
May 15, 2019 |
| Contact name |
Mark Dawson |
| E-mail(s) |
mark.dawson@petermac.org
|
| Organization name |
Peter MacCallum Cancer Centre
|
| Street address |
305 Grattan Street
|
| City |
Melbourne |
| State/province |
VIC |
| ZIP/Postal code |
3000 |
| Country |
Australia |
| |
|
| Platforms (2) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (36)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE88746 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [ChIP-seq 1] |
| GSE88747 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [ChIP-seq 2] |
| GSE88748 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [Click-Seq 1] |
| GSE88749 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [Click-Seq 2] |
| GSE88750 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] |
|
| Relations |
| BioProject |
PRJNA348447 |
Less...
More...